RESEARCH ARTICLE
Nobel Med 2021; 17(3): 190-196

HOW CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS WERE AFFECTED BY THE COVID-19 PANDEMIC

Nurgül Bozkurt, Ali İhsan Bozkurt, Mehmet Parlak
ABSTRACT
Objective: In the study, it was investigated how chronic obstructive pulmonary disease (COPD) patients were affected by the COVID-19 pandemic.

Material and Method: COPD patients followed up by our clinic were called by phone and a questionnaire was applied. Complaints, applications to health institutions, use of masks, smoking and weight change, etc. were included in the questionnaire. Six questions of "The Peritraumatic Distress Inventory", which is used to measure stress during disasters, were also included in the questionnaire. Also, Hospital Anxiety/Depression scale was applied and compared with the pre-pandemic values. The data were analyzed in the SPSS program.

Results: The mean age of 101 COPD patients included in the study was 64.9. During the pandemic period;17.8% of patients have various complaints and, 77% of these patients hesitated and did not go to the health institution.

One of the patients was hospitalized and three of them were taken to outpatient treatment. No one was diagnosed with COVID-19.

During the pandemic period; 95.5% of the patients used masks outside the home. Weight gain was found in 47.5% of cases. One third of smokers reduced their amount of cigarettes. The rate of psychological deterioration (who experience at least one of six anxiety/symptoms) was 34.7%. The rate of fear of contamination with COVID-19 was 22.8%, the rate of "fear of death" was 8.9%. Anxiety/ depression scores and rates increased compared to the pre-pandemic levels, especially depression.

Conclusions: During the pandemic; COPD patients gained weight. Their concerns and anxiety/depression scores increased. It will be useful to evaluate COPD patients in terms of anxiety/depression and weight when applying to the clinic. The majority of COPD patients avoided going to a healthcare services due to contamination concerns, despite their complaints. If the pandemic process is prolonged, it is possible that we will encounter problems in COPD treatment and control.

LIVER AND SYSTEMIC DISEASES

05-09

Sebati Özdemir

REVIEW Nobel Med 2013; 9(2): 5-9

AGING KIDNEY: SENESCENCE OR DISEASE?

10-14

Meltem Gürsu, Rümeyza Kazancıoğlu, Savaş Öztürk

REVIEW Nobel Med 2013; 9(2): 10-14

IMPORTANCE OF HOLOTRANSCOBALAMIN (HOLOTC) MEASUREMENTS IN EARLY DIAGNOSIS OF COBALAMIN DEFICIENCY, ESPECIALLY IN PATIENTS WITH BORDERLINE VITAMIN B12 CONCENTRATIONS

15-20

Faruk Sönmezışık, Esma Sürmen Gür, Burak Asıltaş

RESEARCH ARTICLE Nobel Med 2013; 9(2): 15-20

EVALUATION OF PHYSICAL GROWTH IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

21-25

Celalettin Koşan, Oğuzhan Sepetçigil, Atilla Çayır, Avni Kaya, Behzat Özkan

RESEARCH ARTICLE Nobel Med 2013; 9(2): 21-25

COMPARISON OF RISK INDEXES USED IN DETERMINING THE POSTOPERATIVE RESPIRATORY INSUFFICIENCY RISK

26-31

Gülsüm Kavalcı, Cavidan Arar, Alkın Çolak, Nesrin Turan, Cemil Kavalcı

RESEARCH ARTICLE Nobel Med 2013; 9(2): 26-31

THE EVALUATION OF PRENATAL AND ENVIROMENTAL RISK FACTORS IN CHILDREN WITH ASTHMA, ALLERGIC RHINITIS AND BRONCHIAL ASTHMA ABSTRACT

32-37

Mehmet İbrahim Turan, Müferet Ergüven, Mehmet Özdemir

RESEARCH ARTICLE Nobel Med 2013; 9(2): 32-37

REOPERATIONS AND MORBIDITY IN THYROID SURGERY

38-42

Serkan Teksöz, Murat Özcan, Aytül Sargan, Yusuf Bukey, Recep Özgültekin, Ateş Özyeğin

RESEARCH ARTICLE Nobel Med 2013; 9(2): 38-42

EFFECTS OF RAMADAN FASTING ON BLOOD PRESSURE CONTROL, LIPID PROFILE, BRAIN NATRIURETIC PEPTIDE, RENAL FUNCTIONS AND ELECTROLYTE LEVELS IN HYPERTENSIVE PATIENTS TAKING COMBINATION THERAPY

43-46

İbrahim Faruk Aktürk, İsmail Bıyık, Cüneyt Koşaş, Ahmet Arif Yalçın, Mehmet Ertürk, Fatih Uzun

RESEARCH ARTICLE Nobel Med 2013; 9(2): 43-46

MANAGEMENT OF A LARGE OUTBREAK CAUSED BY NOROVIRUS AND CAMPYLOBACTER JEJUNI OCCURRED IN A RURAL AREA IN TURKEY

47-51

İbak Gönen

RESEARCH ARTICLE Nobel Med 2013; 9(2): 47-51

FREQUENT CD99 AND FLI-1 EXPRESSIONS IN DIFFUSE LARGE B-CELL LYMPHOMA AND THEIR ASSOCIATION WITH PROLIFERATIVE AND APOPTOTIC RATES

52-56

Ufuk Berber, İsmail Yılmaz, Tolga Tuncel, Zafer Küçükodacı Aptullah Haholu

RESEARCH ARTICLE Nobel Med 2013; 9(2): 52-56
  • Pubmed Style
    Nurgül Bozkurt, Ali İhsan Bozkurt, Mehmet Parlak. [KRONİK OBSTRÜKTİF AKCİĞER HASTALIĞI OLAN HASTALARIMIZ COVID-19 PANDEMİSİNDEN NASIL ETKİLENDİ]. Nobel Med 2021; 17(3): 190-196, Turkish.
  • Web Style
    Nurgül Bozkurt, Ali İhsan Bozkurt, Mehmet Parlak. [KRONİK OBSTRÜKTİF AKCİĞER HASTALIĞI OLAN HASTALARIMIZ COVID-19 PANDEMİSİNDEN NASIL ETKİLENDİ]. www.nobelmedicus.com/en/Article.aspx?m=1716 [Access: Mayıs 24, 2021], Turkish.
  • AMA (American Medical Association) Style
    Nurgül Bozkurt, Ali İhsan Bozkurt, Mehmet Parlak. [KRONİK OBSTRÜKTİF AKCİĞER HASTALIĞI OLAN HASTALARIMIZ COVID-19 PANDEMİSİNDEN NASIL ETKİLENDİ]. Nobel Med 2021; 17(3): 190-196, Turkish.
  • Vancouver/ICMJE Style
    Nurgül Bozkurt, Ali İhsan Bozkurt, Mehmet Parlak. [KRONİK OBSTRÜKTİF AKCİĞER HASTALIĞI OLAN HASTALARIMIZ COVID-19 PANDEMİSİNDEN NASIL ETKİLENDİ]. Nobel Med (2021); 17(3): 190-196, [cited Mayıs 24, 2021], Turkish.
  • Harvard Style
    Nurgül Bozkurt, Ali İhsan Bozkurt, Mehmet Parlak. (2021) [KRONİK OBSTRÜKTİF AKCİĞER HASTALIĞI OLAN HASTALARIMIZ COVID-19 PANDEMİSİNDEN NASIL ETKİLENDİ]. Nobel Med, 17(3): 190-196, Turkish.